RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Kwabi-Addo, Bernard
PropertyValue
overview I am an Associate Professor of Biochemistry and Molecular Biology at Howard University, Washington D.C. I obtained my PhD in Molecular Biology from Queen Mary & Westfield College (University of London, UK) where I carried out studies using Cre-loxP site-specific recombination system to design chromosomal translation in transgenic animal model. I carried out my post-doctoral training at Baylor College of Medicine, Houston TX where I undertook research studies of the molecular mechanisms underlying dys-regulation of receptor tyrosine signaling in prostate cancer. I subsequently joined Howard University cancer Center in 2007 as an Assistant Professor and become an Associate Professor in 2011. Currently, I serve as a Principle Investigator of a prostate cancer research laboratory. The focus of my research is 3 fold: First, to understand the role of epigenetic alterations in regulating gene expression in prostate cancer. Second, to evaluate and implement tools for quantitative DNA methylation analysis in support of differences in prostate cancer tumor biology and prostate cancer disparity and finally, to understand how DNA methylation changes can be explored as potential biomarkers (ethnic sensitive biomarkers) for the early detection of cancer and/or progression of the disease.
Search Criteria
  • Epigenetics
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support